Mon, Apr 21, 2014, 10:20 AM EDT - U.S. Markets close in 5 hrs 40 mins

Recent

% | $
Quotes you view appear here for quick access.

ALLIQUA, INC. Message Board

  • thom988 thom988 Mar 22, 2013 7:37 AM Flag

    Alliqua Initiates Life-Cycle Management Plan to Expand Wound Care Portfolio for Use in Broader Wound Indications

     

    NEW YORK, March 22, 2013 /PRNewswire via COMTEX/ -- Alliqua, Inc. (otcqb:ALQA) ("Alliqua" or the "Company") today announced the initiation of a life-cycle management plan as the first phase in their portfolio expansion initiative. As part of this plan, Alliqua is making a number of product changes designed to increase adoption of SilverSeal® and Hydress® dressings. Alliqua intends that these ongoing planned modifications will address the needs of patients with a broader range of wounds as well as the specific needs of their various clinical customers. Customers should expect to see the first of these updated dressings in May 2013.

    "We believe that these changes and the expansion of our dressing portfolio will increase the overall number of patients who can benefit from our technology. Feedback from our customers and a market survey we conducted suggests these changes are important considerations for physicians and patients when selecting a hydrogel dressing," said David Johnson, Alliqua's chief executive officer. "Our life-cycle management initiatives are designed to ensure our SilverSeal® and Hydress® products provide compelling solutions for our customers."

    The Company expects to file a 510(k) application with the FDA for clearance of SilverSeal® incorporating additional modifications by mid 2013, after which a decision from the FDA may be forthcoming as early as the end of the year.

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ALQA
8.08+0.35(+4.53%)9:58 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.